Please join our experienced panel for a review of key takeaways from the FDA’s 2019 drug and device advertising and promotion enforcement letters and a discussion of related regulatory developments. Learn the issues that were most commonly raised in last year’s letters, as well as other important legal and regulatory developments, and what these could mean for your business, including:
- OPDP, APLB, and CDRH enforcement overview
- 2019 advertising and promotion guidance documents
- OPDP research and guidance agendas
- Predictions for what is expected in 2020
Wednesday, January 29, 2020
12:00 P.M. – 1:30 P.M. ET
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, firstname.lastname@example.org. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.
If you have questions concerning this roundtable webinar, email email@example.com.